Navigation Links
China Regulatory and Market Access Pharmaceutical Report (2013)
Date:4/15/2013

NEW YORK, April 15, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

China Regulatory and Market Access Pharmaceutical Report (2013)

http://www.reportlinker.com/p01161196/China-Regulatory-and-Market-Access-Pharmaceutical-Report-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

China Regulatory and Market Access Pharmaceutical Report (2013)

China's pharmaceutical market is booming! The market is growing almost 15% annually and is expected to be about $100 billion dollars in 2017. This brand new report covers the best way to register your drug there and optimize market access to increase sales in China.

Drug regulations are complicated in China. This report discusses clinical trials, required drug documentation for approval, GCP, GMP, etc.

Once your drug is approved, what needs to be done to sell it in China? This report also covers issues like drug pricing, reimbursement, provincial bidding, hospital tenders, etc.

This report includes 17 appendices. They include application forms for pharmaceutical products, a list of Chinese CROs, the essential and national reimbursement drug lists, etc.

Pages: 282 (Including 98 pages of the basic report and 184 pages in the Appendix)

TABLE OF CONTENTS

I. China Pharmaceutical Industry Overview

A. Overview
B. China Pharmaceutical Market Trends
C. China's Pharmaceutical Distribution System
D. Brief Overview of China's Pharmaceutical Regulations
E. China Food and Drug Administration (CFDA)

II. The China Healthcare System

A. History of China's Healthcare System
B. Struggling Healthcare Services Sector
C. 2009 Healthcare Reform
D. Hospitals and Medical Resources
1. Hospitals in China
2. Current Problems in the Hospital Sector
3. Private Investment in the Hospital Sector
4. Hospital Reform
E. Health Insurance in China

III. Drug Registration Regulations

A. Drug Registration Policy
B. Classification of Drugs
C. Drug Registration Applications
D. Application Documents for New Drug Registration
E. Technical Review Guidance for Registration Documents
F. New Drug Registration Process
G. Clinical Trials
H. Timeframe to get an Imported Drug Approved
I. OTC New Drug Registration Process
J. Drug Registration Re-Examination
K. Drug Registration Statistics
L. Classification of Combination Drug-Device Products
M. New Regulatory Changes

IV. Drug Pricing Regulations

A. Overview of Drug Pricing Policy
B. Controls on Drug Pricing
C. Reimbursement Drug Lists
D. NRDL and PRDL Pricing
E. Bidding and Hospital Listing

V. Pharmaceutical Research and Development and Related Regulations

A. China's Research and Development Climate
B. Clinical Research
C. Good Clinical Practice (GCP)
D. GCP-Certified Clinical Research Centers
E. Good Laboratory Practice (GLP)
F. Adverse Event Reporting Requirements

VI. Pharmaceutical Manufacturing Regulations

A. Overview of Manufacturing in China
B. Good Manufacturing Practice (GMP) Regulations
C. GMP Certification
D. Drug Manufacturing Administration
E. Drug Manufacturing Certificate
F. Biological Products

VII. Selling Pharmaceuticals and Related Regulations

A. WTO Agreement on Drug Sales
B. Drug Sales to Hospitals
C. Drug Purchasing System
D. Selling Drugs in Drug Stores
E. Internet Drug Sales
F. Distribution Regulations
1. Current Developments in Drug Distribution
2. Drug Distribution Policy
3. Renewal of Drug Distribution Licenses
G. OTC Drug Sales
H. Regulations on Importing Drugs
I. Drug Recalls
J. Drug Safety
K. Authorized Quality Person

VIII. Marketing Drugs in China and Related Regulations

A. Packaging Requirements

IX. Drug Advertising Regulations

X. Intellectual Property Protection and Patents

A. Intellectual Property in the China Pharmaceutical Market
B. Pharmaceutical Companies Experiencing IPR Problems
C. Administrative Protection (AP)

XI. Setting Up your Business in China

XII. What Other Companies are Doing in China

A. Joint Ventures (JV)
B. Acquisitions
C. Licensing

XIII. Conclusion



APPENDICES

1. Application Form for Pharmaceutical Products
2. Listing of CROs in China
3. Regulatory Specifics for Clinical Trials in China
4. Administrative Provisions for Drug Registration (translated law)
5. Registration for TCM (translated law)
6. Registration for Chemical Drugs (translated law)
7. Registration for Biological Drugs (translated law)
8. Supplemental Drug Application Registration (translated law)
9. Drug Re-Registration Application (translated law)
10. Drug Monitoring Periods
11. Application and Approval Procedures and Timeline for Imported Drugs
12. Application and Approval Procedures and Timeline for Clinical Trials
13. Listing of CFDA-affiliated organizations in China
14. Healthcare Statistics and Pharmaceutical Markets in Asia (charts)
15. The National Essential Drug List (2013): Chemical and Biological Drugs
16. The National Essential Drug List (2009): Chemical and Biological Drugs
17. National Reimbursement Drug List (2009): Western Medicines

To order this report:
China Regulatory and Market Access Pharmaceutical Report (2013)

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. X-BODY Announces Multi-Million Dollar Development Alliance With Jiangsu Hengrui Medicine Co., Ltd., A Leading Pharmaceutical Company In China, To Develop Novel Therapeutic Antibodies For AMD
2. Will Brazil, Russia, India and China Ever Become the Golden Goose of the Future for Life Science and Medical Device Companies?
3. Mindray Medical to Exhibit New Products at 69th China International Medical Equipment Fair
4. China Botanic Pharmaceutical Inc. Announces Receipt of Notice of Failure to Satisfy Continued Listing Letter
5. China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2012 Financial Results
6. Doing Business in China: Research on Chinese Good Manufacturing Practice Regulations for Medical Devices
7. Pharmaceutical Manufacturing in China
8. TriReme Announces Signing of a Master Distribution Agreement in China
9. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
10. Pharma Site Inspection Case Sharing at CPhI China Onsite Forum
11. China Human Immunoglobulin Market & 2013 Beverage Forecasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/10/2017)... 10, 2017   West Pharmaceutical Services, Inc. ... injectable drug administration, today shared the results of a ... improving the intradermal administration of polio vaccines. The study ... in May 2017 by Dr. Ondrej Mach , ... Health Organization (WHO), and recently published in the journal ...
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor ... on sciatica in a new episode of "Success Files," which is an award-winning ... innovation and investigates each subject in-depth with passion and integrity. , Sciatica occurs ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):